Pharmaceutical

WuXi Biologics and Medigene link on T cell engagers for cancer

Global contract research, development and manufacturing organisation (CRDMO) WuXi Biologics has partnered with Medigene.

Aug 11, 2024 - 04:00
WuXi Biologics and Medigene link on T cell engagers for cancer
Global contract research, development and manufacturing organisation (CRDMO) WuXi Biologics has partnered with Medigene.
Read the original article

Tags:

Previous Article

Gilead Sciences reports net income rise in Q2 2024

Next Article

How the GLP-1 receptor agonist market could hit $168bn by 2033

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope

Opinion: The FDA’s approval of a new gene therapy for D...

Jun 22, 2023

Health Canada approves AstraZeneca-Merck’s prostate cancer therapy

Health Canada approves AstraZeneca-Merck’s prostate can...

Jul 15, 2023

As England’s virus hospitalisations surge flu vaccines evolve

As England’s virus hospitalisations surge flu vaccines ...

Feb 2, 2024